Psychiatric treatment often relies on trial-and-error prescribing because biological differences between patients are not routinely used to select therapy.
R&D Focus
Microbiome diagnostics, monitoring, and precision therapeutics
Innovative Solution
GenieBiome is a biotechnology company using microbiome research technology to develop treatments for a variety of diseases, including gut serious illness, overweight and metabolic syndrome, skin irritation, and mental health. GenieBiome’s portfolio of G-NiiB includes diagnostic and risk prediction tests, next-generation microbiome precision formulas, and precision medicine.
Investment Funding
Last Funding Stage
Series B
Total Funding Amount
11.M
Last Funding Amount
11.M
Last Funding Date
01-11-2021
Startup Stage
Early Stage
About
GenieBiome is a biotechnology company using microbiome research technology to develop treatments for a variety of diseases, including gut serious illness, overweight and metabolic syndrome, skin irritation, and mental health. GenieBiome’s portfolio of G-NiiB includes diagnostic and risk prediction tests, next-generation microbiome precision formulas, and precision medicine.
Something missing or incorrect on this page? Help us enrich this information
